Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Translational Cancer Research|July 11, 2017
Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesisMichael I Carr, Stephen N JonesCell Reports|August 30, 2016
Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced TumorigenesisMichael I Carr, Justine E Roderick, Hugh S Gannon, et al.Frontiers in Oncology|March 3, 2020
DNA-PK Inhibitor, M3814, as a New Combination Partner of Mylotarg in the Treatment of Acute Myeloid LeukemiaMichael I Carr, Astrid Zimmermann, Li-Ya Chiu, et al.Proceedings of the National Academy of Sciences of the United States of America|December 14, 2016
Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of miceMichael I Carr, Justine E Roderick, Hong Zhang, et al.Molecular Cancer Research : MCR|September 26, 2019
Therapeutic Implications of p53 Status on Cancer Cell Fate Following Exposure to Ionizing Radiation and the DNA-PK Inhibitor M3814Qing Sun, Yige Guo, Xiaohong Liu, et al.Scientific Reports|June 10, 2021
DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemiaEric Haines, Yuki Nishida, Michael I Carr, et al.Molecular Cancer Research : MCR|January 4, 2022
DNA-PK Inhibitor Peposertib Amplifies Radiation-Induced Inflammatory Micronucleation and Enhances TGFβ/PD-L1 Targeted Cancer ImmunotherapyMichael I Carr, Li-Ya Chiu, Yige Guo, et al.Pageof 1